Molecular Imaging: Page 113

Philips partners with Dutch university

By AuntMinnieEurope.com staff writers

Philips Healthcare will collaborate with VU University Medical Center in Amsterdam, Netherlands, to jointly research new multimodality imaging technologies.

February 21, 2010

PET/CT cost-effective for head, neck squamous cell carcinoma

By Wayne Forrest

FDG-PET/CT is not only most effective for pretreatment screening of distant metastases in patients with head and neck squamous cell carcinoma, the combined modalities do so with no additional costs to healthcare providers, according to researchers in the Netherlands.

February 16, 2010

PET scan can increase accuracy of head/neck cancer staging

By Reuters Health

NEW YORK (Reuters Health), Feb 11 - Squamous cell carcinoma of the head and neck can be staged more accurately with whole-body PET using F-18 FDG, according to European researchers.

February 10, 2010

Siemens orders PET/CT transport system

By AuntMinnieEurope.com staff writers

Siemens Healthcare has ordered the Dignity Carrier patient transportation system from LinkMed.

February 1, 2010

DOPA-PET/CT can alter therapy for neuroendocrine tumors

By Wayne Forrest

Swiss researchers have found that combined fluorine-18 dihydroxyphenylalanine (F-18 DOPA) contrast-enhanced PET/CT is "significantly superior" to DOPA-PET and contrast-enhanced CT in detecting neuroendocrine tumors.

January 14, 2010

Echocardiography test beats SPECT for predicting problems after MI

By Reuters Health

NEW YORK (Reuters Health), Dec 7 - Myocardial contrast echocardiography is superior to nitrate-enhanced SPECT in predicting cardiac death and other cardiac events after acute myocardial infarction, say researchers from the U.K. in the November 1 American Journal of Cardiology.

December 6, 2009

Seasonal variation seen in brown adipose tissue

By Reuters Health

NEW YORK (Reuters Health), Nov 27 - Brown adipose tissue is much more active in humans during the winter than in the summer, according to a report in the November issue of Diabetes. Researchers looked at 3,614 patients who underwent CT and PET, mostly for cancer staging purposes.

November 26, 2009

Functional MRI may help with prognosis for comatose patients

By Wayne Forrest

French researchers have found good agreement between functional MRI (fMRI) and FDG-PET in assessing brain function in comatose patients. Their research indicates that fMRI potentially could help guide treatment of these individuals.

October 25, 2009

Siemens hits milestone Biograph mCT install

By AuntMinnieEurope.com staff writers

Siemens Healthcare has delivered its first Biograph mCT hybrid molecular imaging system in the U.K.

October 20, 2009

FDG-PET and CT useful in melanoma assessment

By Reuters Health

NEW YORK (Reuters Health), Oct 13 - In staging melanoma patients with palpable lymph nodes, fluorine-18 FDG-PET and CT are equivalent, but FDG-PET detects more metastatic sites, particularly bone and subcutaneous metastases, Dutch researchers report in the October 1 issue of the Journal of Clinical Oncology.

October 12, 2009

Dilon lands deal with Philips

By AuntMinnieEurope.com staff writers

Molecular breast imaging developer Dilon Diagnostics has signed a distribution agreement with Philips Healthcare covering markets in Europe and the Middle East.

October 11, 2009

FDG-PET uptake helps predict vascular events in cancer patients

By Wayne Forrest

German researchers have discovered that FDG uptake in major arteries is the "strongest predictor of a subsequent vascular event" in cancer patients, with severe calcification also indicating high risk, according to an article published in the October issue of the Journal of Nuclear Medicine.

October 8, 2009

Previous Page

Page 113 of 122

Next Page